April 30, 2018
Bristol-Myers Squibb and Otsuka Pharmaceuticals have reached settlement agreements with consumers in three cases scheduled for bellwether trials in Florida this summer in multidistrict litigation over side effects of the antipsychotic drug Abilify, according to a Saturday order.
April 05, 2018
Otsuka Pharmaceutical Co. Ltd. and Bristol-Myers Squibb Co. are looking to narrow one of three cases set for trial in multidistrict litigation over side effects of the antipsychotic drug Abilify, arguing the consumers' failure-to-warn claims are unsupported.